Granted Patent
B2
US 8,748,377 · App. 13/133,976 · Granted Jun 10, 2014
Pharmaceutical compositions
Inventors:
Mark A. Bush (Research Triangle Park, NC); Murray W. Stewart (King of Prussia, PA); Yonghong Yang (King of Prussia, PA)
Assignee:
GlaxoSmithKline LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides pharmaceutical compositions comprising at least one polypeptide having GLP-1 activity wherein an effective dose of said pharmaceutical composition comprises 15 mg, 30 mg, 50 mg or 100 mg of said polypeptide having GLP-1 activity. Also provided are methods of administering the pharmaceutical compositions of the invention.
Claims (1)
1. A pharmaceutical composition comprising a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:1 wherein an effective dose of said pharmaceutical composition comprises 30 mg of said polypeptide.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 2, 2013
From: BUSH, MARK A.; STEWART, MURRAY W.; YANG, YONGHONG
To: GLAXOSMITHKLINE LLC
Reel/Frame 030335/0427 →
Continuity (5)
Provisional Application
61121229
· Dec 10, 2008
Provisional Application
61150909
· Feb 9, 2009
Provisional Application
61163995
· Mar 27, 2009
Provisional Application
61238723
· Sep 1, 2009